Belzutifan
About
Therapy type: Targeted therapy
Therapy strategy: HIF-2a inhibition
Mappings
NCI Thesaurus: Belzutifan (coding:ncit:C135627)
RxNorm: belzutifan (coding:rxcui:2567226, coding:omop:701696)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | VHL pathogenic variants | Renal Cell Carcinoma | Belzutifan | |
| FDA (1) | VHL pathogenic variants | Central Nervous System Hemangioblastoma | Belzutifan | |
| FDA (1) | VHL pathogenic variants | Pancreatic Neuroendocrine Tumor | Belzutifan |